F.D.A.’s Review of MDMA Cites Health Risks and Study Flaws

Health
By Andrew Jacobs and Christina Jewett from NYT Health https://ift.tt/N0pMCUP
via IFTTT Psychedelic and Hallucinogenic Drugs, Drug Abuse and Traffic, Veterans, Post-Traumatic Stress Disorder, Mental Health and Disorders, Regulation and Deregulation of Industry, Therapy and Rehabilitation, Drugs (Pharmaceuticals), Clinical Trials, Ecstasy (Drug), Research, Depression (Mental), Placebos, Alternative and Complementary Medicine The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda